Abstract:High blood pressure (BP) is detrimental to brain health. High BP contributes to cognitive impairment and dementia through pathways independent of clinical stroke. Emerging evidence shows that the deleterious effect of high BP on cognition occurs across the life span, increasing the risk for early-onset and late-life dementia. The term vascular cognitive impairment includes cognitive disorders associated with cerebrovascular disease, regardless of the pathogenesis. This focused report is a narrative review that… Show more
“…In our study, total brain volume atrophy and cognitive decline were associated with increased night BPV, but not with night mean BP. It is well-known that high BP contributes to cognitive impairments and dementia ( 3 , 28 ). However, despite excellent BP control in a post-hoc analysis of the SPRINT MIND trial, higher BPV was associated with an increased risk of dementia ( 29 ), suggesting that increased BPV might be an independent factor associated with brain damage.…”
Section: Discussionmentioning
confidence: 99%
“…This study included 1,967 subjects who examined 24-h ABPM during the baseline period (2011–2014) ( Figure 1 ). We excluded 224 subjects with the following conditions: ( 1 ) valid 24-h ABPM ≤ 70% of the readings of total 24-h BP measurements ( n = 202); ( 2 ) cerebrovascular disease ( n = 10); and ( 3 ) any cancer ( n = 12). Among the remaining 1,743 subjects, 1,438 individuals underwent both baseline and follow-up brain MRI scans.…”
Section: Methodsmentioning
confidence: 99%
“…KoGES participants were administered the neuropsychological assessment battery described below during the regular examination cycle as part of the baseline measurement of the aging study: ( 1 ) story recall test, immediate and delayed recall, and recognition; ( 2 ) visual reproduction, immediate and delayed recall, and recognition; ( 3 ) verbal fluency; ( 4 ) trail making tests; ( 5 ) Digit Symbol-coding, incidental learning, and free recall; and ( 6 ) Korean-Color Word Stroop Test, word reading, and color reading. Standard administration protocols were used for each testing session, and the tests were conducted by well-trained and experienced psychological examiners.…”
Section: Methodsmentioning
confidence: 99%
“…High blood pressure (BP) has been shown to be associated with brain atrophy and cognitive dysfunctions ( 1 – 3 ). Nocturnal hypertension showed significant associations with brain volume and cognitive impairment ( 1 , 4 , 5 ).…”
BackgroundAlthough blood pressure variability (BPV) has emerged as a novel risk factor for Alzheimer's disease, few studies have examined the effects of night BPV on brain structure and function. This study investigated the association of night BPV with brain atrophy and cognitive function changes.MethodsThe analysis included 1,398 participants with valid ambulatory blood pressure (BP) monitoring at baseline and both baseline and 4-year follow-up brain magnetic resonance images who were recruited from the Korean Genome and Epidemiology Study. Participants underwent a comprehensive neuropsychological test battery. BPV was derived from ambulatory BP monitoring and calculated as a standard deviation (SD) of 24-h and daytime and nighttime BP.ResultsDuring the median follow-up of 4.3 years, increased SD of night systolic or diastolic BP was an indicator of total brain volume reduction, while daytime BPV or night average BP was not associated with total brain volume changes. High SD of night systolic BP was associated with reduced gray matter (GM) volume, independent of average night BP, and use of antihypertensive drugs. It also was associated with a reduction of temporal GM volume, mostly driven by atrophy in the left entorhinal cortex and the right fusiform gyrus. In cognitive performance, high variability of night systolic BP was associated with a decrease in visual delayed recall memory and verbal fluency for the category.ConclusionIncreased night BPV, rather than night mean BP, was associated with reduced brain volume and cognitive decline. High night BPV could be an independent predictor for rapid brain aging in a middle-aged population.
“…In our study, total brain volume atrophy and cognitive decline were associated with increased night BPV, but not with night mean BP. It is well-known that high BP contributes to cognitive impairments and dementia ( 3 , 28 ). However, despite excellent BP control in a post-hoc analysis of the SPRINT MIND trial, higher BPV was associated with an increased risk of dementia ( 29 ), suggesting that increased BPV might be an independent factor associated with brain damage.…”
Section: Discussionmentioning
confidence: 99%
“…This study included 1,967 subjects who examined 24-h ABPM during the baseline period (2011–2014) ( Figure 1 ). We excluded 224 subjects with the following conditions: ( 1 ) valid 24-h ABPM ≤ 70% of the readings of total 24-h BP measurements ( n = 202); ( 2 ) cerebrovascular disease ( n = 10); and ( 3 ) any cancer ( n = 12). Among the remaining 1,743 subjects, 1,438 individuals underwent both baseline and follow-up brain MRI scans.…”
Section: Methodsmentioning
confidence: 99%
“…KoGES participants were administered the neuropsychological assessment battery described below during the regular examination cycle as part of the baseline measurement of the aging study: ( 1 ) story recall test, immediate and delayed recall, and recognition; ( 2 ) visual reproduction, immediate and delayed recall, and recognition; ( 3 ) verbal fluency; ( 4 ) trail making tests; ( 5 ) Digit Symbol-coding, incidental learning, and free recall; and ( 6 ) Korean-Color Word Stroop Test, word reading, and color reading. Standard administration protocols were used for each testing session, and the tests were conducted by well-trained and experienced psychological examiners.…”
Section: Methodsmentioning
confidence: 99%
“…High blood pressure (BP) has been shown to be associated with brain atrophy and cognitive dysfunctions ( 1 – 3 ). Nocturnal hypertension showed significant associations with brain volume and cognitive impairment ( 1 , 4 , 5 ).…”
BackgroundAlthough blood pressure variability (BPV) has emerged as a novel risk factor for Alzheimer's disease, few studies have examined the effects of night BPV on brain structure and function. This study investigated the association of night BPV with brain atrophy and cognitive function changes.MethodsThe analysis included 1,398 participants with valid ambulatory blood pressure (BP) monitoring at baseline and both baseline and 4-year follow-up brain magnetic resonance images who were recruited from the Korean Genome and Epidemiology Study. Participants underwent a comprehensive neuropsychological test battery. BPV was derived from ambulatory BP monitoring and calculated as a standard deviation (SD) of 24-h and daytime and nighttime BP.ResultsDuring the median follow-up of 4.3 years, increased SD of night systolic or diastolic BP was an indicator of total brain volume reduction, while daytime BPV or night average BP was not associated with total brain volume changes. High SD of night systolic BP was associated with reduced gray matter (GM) volume, independent of average night BP, and use of antihypertensive drugs. It also was associated with a reduction of temporal GM volume, mostly driven by atrophy in the left entorhinal cortex and the right fusiform gyrus. In cognitive performance, high variability of night systolic BP was associated with a decrease in visual delayed recall memory and verbal fluency for the category.ConclusionIncreased night BPV, rather than night mean BP, was associated with reduced brain volume and cognitive decline. High night BPV could be an independent predictor for rapid brain aging in a middle-aged population.
“…Hypertension (HTN) is a major cause of death and disability worldwide, and a leading risk factor for dementia 1 . Although there have been significant advances in the pharmacotherapy, a sizable proportion of patients have uncontrolled or resistant HTN which is particularly damaging to the brain 2, 3 .…”
Hypertension, a disease afflicting over one billion individuals worldwide, is a leading cause of cognitive impairment, the mechanisms of which remain poorly understood. In a mouse model of hypertension involving brain angiotensin signaling, we found that the neurovascular and cognitive dysfunction depends on IL-17, a cytokine elevated in the circulation of hypertensive individuals. However, neither circulating IL-17 or brain angiotensin signaling could account in full for the dysfunction. Rather, IL-17 produced by meningeal T-cells was the major culprit by activating IL-17 receptors on brain associated macrophages. Accordingly, depleting brain macrophages or suppressing meningeal T cells completely rescued cognitive function without attenuating blood pressure elevation, circulating IL-17 or brain angiotensin signaling. The data unveil a critical role of meningeal T-cells and macrophage IL-17 signaling in the neurovascular and cognitive dysfunction of hypertension and suggest novel therapies to counteract the devastating effects of hypertension on cognitive health.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.